These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27642346)

  • 1. Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden.
    Hajarizadeh B; Razavi-Shearer D; Merat S; Alavian SM; Malekzadeh R; Razavi H
    Hepat Mon; 2016 Jul; 16(7):e37234. PubMed ID: 27642346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
    J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projections of the current and future disease burden of hepatitis C virus infection in Malaysia.
    McDonald SA; Dahlui M; Mohamed R; Naning H; Shabaruddin FH; Kamarulzaman A
    PLoS One; 2015; 10(6):e0128091. PubMed ID: 26042425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.
    Aljumah AA; Abaalkhail F; Al-Ashgar H; Assiri A; Babatin M; Al Faleh F; Alghamdi A; Al-Hakeem R; Hashim A; Alqutub A; Razavi H; Sanai FM; Al-Swat K; Schmelzer J; Altraif I
    Saudi J Gastroenterol; 2016; 22(4):269-81. PubMed ID: 27488321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection in Argentina: Burden of chronic disease.
    Ridruejo E; Bessone F; Daruich JR; Estes C; Gadano AC; Razavi H; Villamil FG; Silva MO
    World J Hepatol; 2016 May; 8(15):649-58. PubMed ID: 27239258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms.
    Willemse SB; Razavi-Shearer D; Zuure FR; Veldhuijzen IK; Croes EA; van der Meer AJ; van Santen DK; de Vree JM; de Knegt RJ; Zaaijer HL; Reesink HW; Prins M; Razavi H
    Neth J Med; 2015 Nov; 73(9):417-31. PubMed ID: 26582807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C in the Czech Republic: Forecasting the disease burden.
    Fraňková S; Urbánek P; Husa P; Němeček V; Razavi H; Razavi-Shearer D; Chlíbek R; Šperl J
    Cent Eur J Public Health; 2019 Jun; 27(2):93-98. PubMed ID: 31241282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus: A time for decisions. Who should be treated and when?
    Attar BM; Van Thiel DH
    World J Gastrointest Pharmacol Ther; 2016 Feb; 7(1):33-40. PubMed ID: 26855810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward).
    Dore GJ; Ward J; Thursz M
    J Viral Hepat; 2014 May; 21 Suppl 1():1-4. PubMed ID: 24713003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
    Meijerink H; White RA; Løvlie A; de Blasio BF; Dalgard O; Amundsen EJ; Melum E; Kløvstad H
    BMC Infect Dis; 2017 Aug; 17(1):541. PubMed ID: 28774261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment.
    Hajarizadeh B; Grebely J; McManus H; Estes C; Razavi H; Gray RT; Alavi M; Amin J; McGregor S; Sievert W; Thompson A; Dore GJ
    J Gastroenterol Hepatol; 2017 Jan; 32(1):229-236. PubMed ID: 27197716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health impact of comprehensive hepatitis C screening and treatment in the French baby-boomer population.
    Ethgen O; Sanchez Gonzalez Y; Jeanblanc G; Duguet A; Misurski D; Juday T
    J Med Econ; 2017 Feb; 20(2):162-170. PubMed ID: 27590836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.
    Mohaghegh Shalmani H; Noori A; Shokoohi M; Khajavi A; Darvishi M; Delavari A; Jamshidi HR; Naderimagham S
    Arch Iran Med; 2015 Aug; 18(8):508-14. PubMed ID: 26265519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A micro-elimination approach to addressing hepatitis C in Turkey.
    Idilman R; Razavi H; Robbins-Scott S; Akarca US; Örmeci N; Kaymakoglu S; Aygen B; Tozun N; Güner R; Bodur H; Lazarus JV
    BMC Health Serv Res; 2020 Mar; 20(1):249. PubMed ID: 32209103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates on HCV disease burden worldwide - filling the gaps.
    Wedemeyer H; Dore GJ; Ward JW
    J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forecasting the disease burden of chronic hepatitis C virus in Poland.
    Flisiak R; Halota W; Tomasiewicz K; Kostrzewska K; Razavi HA; Gower EE
    Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):70-6. PubMed ID: 25426979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.